Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
VCI Global Announces Termination of Its At-the-Market Offering Program
-
Intelligent Bio Solutions Concludes In-Clinic Testing for Clinical Study Plan, Advancing Toward FDA 510(k) Submission
-
Sculpture Hospitality Launches Innovative Ordering Feature to Streamline Inventory Management
-
Eyenovia, Inc. Announces Pricing of $4 Million Registered Direct Offering
-
Latin Metals Announces Closing of Private Placement for Gross Proceeds of $2.0 Million
-
Coherent Announces Sale of UK Manufacturing Facility Following Strategic Review
-
Form 8.3 - AXA INVESTMENT MANAGERS: Rightmove plc
-
SEO Rank Media: A New Digital Marketing Agency Making Waves in Los Angeles, California
-
Crypto Derivatives Market Rebounds Amid Positive Sentiment, Bybit x Block Scholes Report Finds
-
High Tide Makes the Report on Business Annual Ranking of Canada's Top Growing Companies for Fourth Consecutive Year
-
Axtria Recognized for Excellence in AI with a Minsky Award at Cypher 2024
-
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on October 2, 2024
-
Ocean Power Technologies Ships Multiple Unmanned Surface Vehicles to US Government
-
Blink Charging Surpasses 100,000 Charger Milestone
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
Duke Energy continues with power restoration; nearly 198,000 customers restored following Hurricane Helene's landfall
-
EOLA Power Named to the 14th Annual GrowFL Florida Companies to Watch Awards
-
Alliance Trust PLC - Net Asset Value
-
Lifordi Named Winner of Endpoints 11 as Developer of Antibody Drug Conjugates for Autoimmune and Inflammatory Diseases
-
Novel combination of TALVEY® (talquetamab-tgvs) and TECVAYLI® (teclistamab-cqyv) suggests high response rates and durable responses in triple-class refractory patients with relapsed or refractory mu
-
Avantor® to Host Third Quarter 2024 Earnings Call on Friday, October 25, 2024
-
Savara Announces Expanded Access Program (EAP) for Molgramostim Inhalation Solution (Molgramostim) for Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
-
StepStone Group Completes Fundraising for Fifth Private Equity Secondaries Program at $7.4 billion
-
Iconic California Rock Band, The Mother Hips, Announce New Album, California Current on Blue Rose
-
New research on alpha-synuclein biomarker assays advance the field regarding quantification and disease differentiation
-
Sterling Organization Acquires Portfolio of Shopping Centers Totaling Almost One Million Square Feet for $180.5 Million
-
Salt Life Brand Acquired by Iconix International Inc. in Partnership With the Hilco Consumer-Retail Group
-
Red Shedman Farm Brewery and Hop Yard is Significantly Damaged by Fire
-
Brown Plus' Human Resources Department Named One of the Best HR Teams in 2024 by Best Companies Group
-
Jumbo's Pumpkin Patch Celebrates 30th Anniversary: A Legacy of Family, Farming, and Fun
-
Magentrix Corporation Achieves Prestigious ISO 27001 Certification
-
Maryland Small Business Owner Brynne Krispin Honored as One of The Daily Record's Leading Women Under 40
-
Hyperlink InfoSystem Takes the Spotlight as a Top AI Development Company in USA 2024
-
AeroPress, Inc. Debuts Premium Glass & Metal Coffee Press
-
TAYLOR DEVICES ANNOUNCES FIRST QUARTER RESULTS
-
York Space Systems Successfully Demonstrates Orbit Maneuverability with Tranche 0 Satellites
-
WeightWatchers Announces Executive Leadership Transition
-
Red Lake School District #38 Unveils New Electric School Buses
-
LONGUEVUE CAPITAL EXPANDS PINNACLE CLINICAL RESEARCH PLATFORM WITH ACQUISITION OF JUBILEE CLINICAL RESEARCH
-
TALVEY® (talquetamab-tgvs) and DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) based combination shows deep and durable responses in patients with relapsed or refractory multiple myeloma
-
Hurco Celebrates Successful IMTS as Show Generates Excitement Over Technological Advancements
-
SEALSQ Research Receives Recognition at CRYPTOLOGY2024 for Post-Quantum Work
-
Mercy Executive Named Among Top Data/AI Leaders in Nation
-
Royal designation for Van Leeuwen Pipe and Tube Group
-
Odyssey Therapeutics Announces Formation of Scientific Advisory Board
-
Lexicon to Present Phase 3 Trial Design for Sotagliflozin in Hypertrophic Cardiomyopathy (HCM) at Upcoming Medical Congress
-
Cardurion Pharmaceuticals Selected as an Endpoints 11 Most Promising Biotech Company
-
REX Shares and Tuttle Capital Management Launch T-REX 2X Long NFLX Daily Target ETF (CBOE: NFLU)
-
GreenFirst Announces Shareholder Approval and Expected Effective Date of Share Consolidation and Share Split
-
BioProtect Balloon Spacer Study Published in International Journal of Radiation Oncology, Biology, Physics and Featured at ASTRO 2024, Demonstrates Significant Rectal Protection
